142 related articles for article (PubMed ID: 28554226)
1. Radiofrequency ablation using a multiple-electrode switching system for hepatocellular carcinoma within the Milan criteria: long-term results.
Tan Y; Jiang J; Wang Q; Guo S; Ma K; Bie P
Int J Hyperthermia; 2018 May; 34(3):298-305. PubMed ID: 28554226
[TBL] [Abstract][Full Text] [Related]
2. Hepatocellular Carcinoma within Milan Criteria: No-Touch Multibipolar Radiofrequency Ablation for Treatment-Long-term Results.
Seror O; N'Kontchou G; Nault JC; Rabahi Y; Nahon P; Ganne-Carrié N; Grando V; Zentar N; Beaugrand M; Trinchet JC; Diallo A; Sellier N
Radiology; 2016 Aug; 280(2):611-21. PubMed ID: 27010381
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for the recurrence of early hepatocellular carcinoma treated by percutaneous radiofrequency ablation with a multiple-electrode switching system: a multicenter prospective study.
Tan Y; Wang X; Ma K; Zhang L; Li J; Chen P; Zhang B
Int J Hyperthermia; 2022; 39(1):190-199. PubMed ID: 35042449
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of radiofrequency ablation as first-line therapy for hepatocellular carcinoma less than 3 cm in potentially transplantable patients.
Doyle A; Gorgen A; Muaddi H; Aravinthan AD; Issachar A; Mironov O; Zhang W; Kachura J; Beecroft R; Cleary SP; Ghanekar A; Greig PD; McGilvray ID; Selzner M; Cattral MS; Grant DR; Lilly LB; Selzner N; Renner EL; Sherman M; Sapisochin G
J Hepatol; 2019 May; 70(5):866-873. PubMed ID: 30615906
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcome of percutaneous radiofrequency ablation in recurrent hepatocellular carcinoma after liver transplantation.
Yang W; Wu H; Zhang ZY; Lee JC; Wang S; Wang YJ; Wu W; Chen MH; Yan K
Int J Hyperthermia; 2018 Feb; 34(1):68-76. PubMed ID: 28540818
[TBL] [Abstract][Full Text] [Related]
6. Virologic control and severity of liver disease determine survival after radiofrequency ablation of hepatocellular carcinoma on cirrhosis.
Allaire M; Rekik S; Layese R; Mumana A; Guyot E; Nkontchou G; Bourcier V; Grando V; Ziol M; Nahon P; Ganne-Carrié N; Sutter O; Audureau E; Seror O; Nault JC
Dig Liver Dis; 2019 Jan; 51(1):86-94. PubMed ID: 30126822
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for exceeding the Milan criteria after successful radiofrequency ablation in patients with early-stage hepatocellular carcinoma.
Tsuchiya K; Asahina Y; Tamaki N; Yasui Y; Hosokawa T; Ueda K; Nakanishi H; Itakura J; Kurosaki M; Enomoto N; Izumi N
Liver Transpl; 2014 Mar; 20(3):291-7. PubMed ID: 24734314
[TBL] [Abstract][Full Text] [Related]
8. Long-term follow-up of unresectable medium-large hepatocellular carcinoma nodules treated with radiofrequency ablation using a multiple-electrode switching system.
Francica G; Altiero M; Laccetti E; Pezzullo F; Tanga M; Avitabile G; Elameer M; Scaglione M
Br J Radiol; 2019 Jan; 92(1093):20180625. PubMed ID: 30272482
[TBL] [Abstract][Full Text] [Related]
9. [Efficacy of microwave ablation in treatment of hepatocellular carcinoma within the Milan criteria: a report of 696 cases].
Wang YM; Qian GJ; Xu Y; Wang N; Sheng YH
Zhonghua Gan Zang Bing Za Zhi; 2017 May; 25(5):344-348. PubMed ID: 28763840
[No Abstract] [Full Text] [Related]
10. Long-term survival of hepatocellular carcinoma after percutaneous radiofrequency ablation guided by ultrasound.
Zhang W; Luo E; Gan J; Song X; Bao Z; Zhang H; Chen M
World J Surg Oncol; 2017 Jul; 15(1):122. PubMed ID: 28679433
[TBL] [Abstract][Full Text] [Related]
11. Serum alpha-fetoprotein response can predict prognosis in hepatocellular carcinoma patients undergoing radiofrequency ablation therapy.
Kao WY; Chiou YY; Hung HH; Su CW; Chou YH; Wu JC; Huo TI; Huang YH; Wu WC; Lin HC; Lee SD
Clin Radiol; 2012 May; 67(5):429-36. PubMed ID: 22153231
[TBL] [Abstract][Full Text] [Related]
12. Radiofrequency ablation of hepatocellular carcinoma as first-line treatment: long-term results and prognostic factors in 162 patients with cirrhosis.
Lee DH; Lee JM; Lee JY; Kim SH; Yoon JH; Kim YJ; Han JK; Choi BI
Radiology; 2014 Mar; 270(3):900-9. PubMed ID: 24475823
[TBL] [Abstract][Full Text] [Related]
13. Radiofrequency Ablation Following Downstaging of Hepatocellular Carcinoma by Using Transarterial Chemoembolization: Long-term Outcomes.
Shi F; Wu M; Lian SS; Mo ZQ; Gou Q; Xu RD; Li HL; Huang ZM; Wu PH; Chen XM
Radiology; 2019 Dec; 293(3):707-715. PubMed ID: 31638492
[TBL] [Abstract][Full Text] [Related]
14. Radiofrequency ablation of hepatocellular carcinoma in difficult locations: Strategies and long-term outcomes.
Yang W; Yan K; Wu GX; Wu W; Fu Y; Lee JC; Zhang ZY; Wang S; Chen MH
World J Gastroenterol; 2015 Feb; 21(5):1554-66. PubMed ID: 25663774
[TBL] [Abstract][Full Text] [Related]
15. Post-ablation des-gamma-carboxy prothrombin level predicts prognosis in hepatitis B-related hepatocellular carcinoma.
Lee S; Rhim H; Kim YS; Kang TW; Song KD
Liver Int; 2016 Apr; 36(4):580-7. PubMed ID: 26503910
[TBL] [Abstract][Full Text] [Related]
16. Initial treatment response is essential to improve survival in patients with hepatocellular carcinoma who underwent curative radiofrequency ablation therapy.
Takahashi S; Kudo M; Chung H; Inoue T; Ishikawa E; Kitai S; Tatsumi C; Ueda T; Minami Y; Ueshima K; Haji S
Oncology; 2007; 72 Suppl 1():98-103. PubMed ID: 18087189
[TBL] [Abstract][Full Text] [Related]
17. Small- and medium-sized hepatocellular carcinomas: monopolar radiofrequency ablation with a multiple-electrode switching system-mid-term results.
Woo S; Lee JM; Yoon JH; Joo I; Kim SH; Lee JY; Yoon JH; Kim YJ; Han JK; Choi BI
Radiology; 2013 Aug; 268(2):589-600. PubMed ID: 23513241
[TBL] [Abstract][Full Text] [Related]
18. Radiofrequency ablation of hepatocellular carcinoma: long-term results and prognostic factors in 235 Western patients with cirrhosis.
N'Kontchou G; Mahamoudi A; Aout M; Ganne-Carrié N; Grando V; Coderc E; Vicaut E; Trinchet JC; Sellier N; Beaugrand M; Seror O
Hepatology; 2009 Nov; 50(5):1475-83. PubMed ID: 19731239
[TBL] [Abstract][Full Text] [Related]
19. Radiofrequency ablation
Conticchio M; Inchingolo R; Delvecchio A; Laera L; Ratti F; Gelli M; Anelli F; Laurent A; Vitali G; Magistri P; Assirati G; Felli E; Wakabayashi T; Pessaux P; Piardi T; di Benedetto F; de'Angelis N; Briceño J; Rampoldi A; Adam R; Cherqui D; Aldrighetti LA; Memeo R
World J Gastroenterol; 2021 May; 27(18):2205-2218. PubMed ID: 34025074
[TBL] [Abstract][Full Text] [Related]
20. Radiofrequency ablation for HCC patients with multifocal tumours meeting the Milan criteria: A single-centre experience.
Zhang W; Jiang L; Yan L; Yang J; Li B; Wen T; Zeng Y; Wang W; Xu M
Dig Liver Dis; 2016 Dec; 48(12):1485-1491. PubMed ID: 27495779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
